Literature DB >> 18174287

Mechanisms of adrenocorticotropin-induced activation of extracellularly regulated kinase 1/2 mitogen-activated protein kinase in the human H295R adrenal cell line.

Mandy E Janes1, K M Emily Chu, Adrian J L Clark, Peter J King.   

Abstract

The role of ACTH in stimulating or inhibiting growth of adrenal cells has been a subject of some controversy. Reports that ACTH may stimulate ERK/MAPK in Y1 cells have suggested a role for cAMP in this process. In attempting to extend this work, the ACTH responses in the human H295R cell line have been studied. This cell line makes only a very modest cAMP response to ACTH, yet the ERK1/2 response is highly reproducible and immediate but not prolonged. It is minimally reduced by the protein kinase A inhibitor, H89, but unaffected by protein kinase C and calcium inhibitors. Inhibition of epidermal growth factor receptor or other tyrosine kinase receptor transactivation was without effect, as was inhibition of c-Src activity or c-Src phosphorylation. The most effective inhibitor of this pathway was dansylcadaverine, an inhibitor of receptor internalization. These findings imply that ACTH-induced ERK1/2 activation in H295R cells is dependent on a mechanism distinct from that by which most G protein-coupled receptors activate ERK1/2 but that nevertheless seems to depend on receptor internalization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174287     DOI: 10.1210/en.2007-0949

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

Review 2.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

3.  RhoA and DIAPH1 mediate adrenocorticotropin-stimulated cortisol biosynthesis by regulating mitochondrial trafficking.

Authors:  Donghui Li; Marion B Sewer
Journal:  Endocrinology       Date:  2010-06-30       Impact factor: 4.736

Review 4.  Human adrenocortical carcinoma cell lines.

Authors:  Tao Wang; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

5.  Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line.

Authors:  Jeniel Parmar; Rebecca E Key; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2008-08-19       Impact factor: 5.958

6.  Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior.

Authors:  Yuichi Ikeda; Hidetoshi Kumagai; Amber Skach; Makito Sato; Masashi Yanagisawa
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

7.  A case of congenital adrenal hyperplasia mimicking Cushing's syndrome.

Authors:  Hye Jeong Kim; Mira Kang; Jae Hyeon Kim; Sun Wook Kim; Jae Hoon Chung; Yong-Ki Min; Moon-Kyu Lee; Kwang-Won Kim; Myung-Shik Lee
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

Review 8.  Comparative Effect of ACTH and Related Peptides on Proliferation and Growth of Rat Adrenal Gland.

Authors:  Claudimara Ferini Pacicco Lotfi; Pedro O R de Mendonca
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-09       Impact factor: 5.555

9.  cAMP-stimulated phosphorylation of diaphanous 1 regulates protein stability and interaction with binding partners in adrenocortical cells.

Authors:  Donghui Li; Eric B Dammer; Natasha C Lucki; Marion B Sewer
Journal:  Mol Biol Cell       Date:  2013-01-16       Impact factor: 4.138

Review 10.  Role of Protein Phosphorylation and Tyrosine Phosphatases in the Adrenal Regulation of Steroid Synthesis and Mitochondrial Function.

Authors:  Cristina Paz; Fabiana Cornejo Maciel; Alejandra Gorostizaga; Ana F Castillo; M Mercedes Mori Sequeiros García; Paula M Maloberti; Ulises D Orlando; Pablo G Mele; Cecilia Poderoso; Ernesto J Podesta
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.